Vol. 15 No. 4 (2009)

DOI: https://doi.org/10.5912/jcb.v15i4

Published: 2009-10-01

Editorial

Intellectual property and biotechnology innovation: To protect or not protect?

Yali Friedman
- PDF

Commentary

The correlation between medical tourism and biotechnology

David G Vequist IV, Erika Valdez
- Requires Subscription PDF (USD 25)
The VC manifesto: Special pleading for a damaged cause: Commentary on Simon Witney interview

William Bains
- Requires Subscription PDF (USD 25)

Article

Innovate America: The Technology Innovation Program at NIST

Andrew S Klein, Mrunal S Chapekar
- Requires Subscription PDF (USD 25)
Valuation of complex license contracts

Ralph Villiger, Boris Bogdan
- PDF
How can pharmaceutical and biotechnology companies maintain a high profitability?

Klaus J Nickisch, Joachim M Greuel, Kerstin M Bode-Greuel
- Requires Subscription PDF (USD 25)
Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industry

J Leslie Glick
- PDF
Building biotechnology teams: Personality does matter

Anne S York, Kim A McCarthy, Todd C Darnold
- PDF
Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement

Rob Hanes, Damon Borich
- PDF

Legal and Regulatory Updates

Legal and Regulatory Update

Gerry Kamstra, John Wilkinson
- Requires Subscription PDF (USD 25)

Book Review